Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Conference News EACTS 2025

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

Yael L. Maxwell

October 10, 2025

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

L.A. McKeown

October 09, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Conference News NY Valves 2025

Long-term Survival Better With TAVI Explant vs Redo: Medicare Data

Yael L. Maxwell

June 26, 2025

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

L.A. McKeown

May 22, 2025

News Conference News VEITH 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

L.A. McKeown

November 26, 2019

News Conference News VEITH 2015

EVAR Takes the Lead in Continuing Debate Over Best Therapy for Ruptured AAAs

Caitlin E. Cox

November 24, 2015

News Industry News

First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations

October 20, 2015

News Daily News

具有未治疗的较大AAA的患者中破裂发生率低于以前的预期

February 25, 2015

News Daily News

Rupture Rates in Patients With Untreated Large AAAs Lower Than Previously Thought

February 25, 2015

Advertisement

TCTMD’s Top 10 Most Popular Stories for October 2025

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

September 2025 Dispatch for the CV Team

Long-term Survival Better With TAVI Explant vs Redo: Medicare Data

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

EVAR Takes the Lead in Continuing Debate Over Best Therapy for Ruptured AAAs

First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations

具有未治疗的较大AAA的患者中破裂发生率低于以前的预期

Rupture Rates in Patients With Untreated Large AAAs Lower Than Previously Thought

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content